Nabil Sifo @NabilSifo: "𝐏𝐨𝐫𝐭𝐟𝐨𝐥𝐢𝐨 𝐮𝐩𝐝𝐚𝐭𝐞: 𝐀 𝐥𝐨𝐨𝐤 𝐚𝐭..."

Germany

Edited

𝐏𝐨𝐫𝐭𝐟𝐨𝐥𝐢𝐨 𝐮𝐩𝐝𝐚𝐭𝐞: 𝐀 𝐥𝐨𝐨𝐤 𝐚𝐭 𝐒𝐞𝐩𝐭𝐞𝐦𝐛𝐞𝐫 𝐩𝐞𝐫𝐟𝐨𝐫𝐦𝐚𝐧𝐜𝐞 Dear Copiers and followers, Here is the monthly portfolio update. a little later than usual this Sunday evening as I was traveling over the weekend, but I still managed to get it out before the new week begins. This one will be slightly longer than usual, as there’s plenty to cover. 𝐏𝐞𝐫𝐟𝐨𝐫𝐦𝐚𝐧𝐜𝐞 𝐑𝐞𝐜𝐚𝐩 We had a strong month behind us, closing at 6.97%, again ahead of both the $SPX500 and the $NSDQ100 . September was not a quiet and boring month, as there was elevated volatility, or in other words, opportunities to buy the dip. 𝐏𝐨𝐫𝐭𝐟𝐨𝐥𝐢𝐨 𝐒𝐭𝐚𝐭𝐢𝐬𝐭𝐢𝐜𝐬 • Closed trades: 9 • Profitability rate: 100% • Realized profit: +1.33% We successfully exited positions in $NVDA (NVIDIA Corporation) and $BNP.PA (BNP Paribas SA) locking in profits and freeing up capital for more aggressive growth opportunities. Overall, the portfolio continues to move steadily upward in what has been the strongest year so far. 𝐏𝐨𝐫𝐭𝐟𝐨𝐥𝐢𝐨 𝐜𝐡𝐚𝐧𝐠𝐞𝐬: During the first 10 days of September, I focused on buying dips in existing positions: • Added to $DTE (DTE Energy Co) (still not fully bottomed) • Added to $ONON (On Holding AG), a stock I like but which hasn’t yet performed as I expected Later in the month, after exiting two stable, low-volatility positions, I shifted toward more aggressive growth plays with the secured funds.The increased investments were: 𝐈𝐧𝐜𝐫𝐞𝐚𝐬𝐞𝐝 𝐢𝐧𝐯𝐞𝐬𝐭𝐦𝐞𝐧𝐭𝐬: • $CELH (Celsius Holdings Inc.) • $BTC 𝐍𝐞𝐰 𝐩𝐨𝐬𝐢𝐭𝐢𝐨𝐧𝐬: • $CRMD (CorMedix Inc) • $LFMD (LifeMD Inc) 𝐖𝐡𝐲 𝐢𝐧𝐜𝐫𝐞𝐚𝐬𝐞 𝐭𝐡𝐞 𝐜𝐫𝐲𝐩𝐭𝐨 𝐞𝐱𝐩𝐨𝐬𝐮𝐫𝐞? Long time copiers know that I stick to a maximum 5% crypto exposure in this portfolio, as I believe crypto is hard to analyze fundamentally. Now, after the last buy of $BTC , we are almost at 6.5% crypto exposure. The reason: Bitcoin is increasingly being recognized as a strategic reserve asset, with growing adoption among high-net-worth individuals. I added $BTC as a hedge against stock market volatility, which worked well in September. This remains a long term holding in the portfolio. 𝐇𝐞𝐚𝐥𝐭𝐡 𝐒𝐭𝐨𝐜𝐤𝐬 𝐁𝐞𝐭 To accelerate growth, I added two healthcare stocks: LifeMD and CorMedix Both are currently trading at discounted levels, offering what I see as attractive entry points. As hyper growth, mid to low market cap plays, these positions will require patience before we can fairly judge their outcomes. Interestingly, the healthcare sector gained momentum last week, partly due to U.S. Congressional debates around healthcare spending. This was reflected in health insurance names like $OSCR (Oscar Health Inc) and $UNH (UnitedHealth) . The coming weeks could bring further movement in this sector. $HIMS (Hims & Hers Health Inc) , The stock fell 10% following news of a COO change. Given the naturally volatile nature of $HIMS, this move is not a major concern. 𝐅𝐢𝐧𝐚𝐥𝐥𝐲: September was a strong month. Steady gains, successful exits, and a shift toward higher growth opportunities. With increased exposure to both crypto and healthcare, the portfolio is positioned for continued momentum into Q4. Best regards, Nabil Sifo I am a professional risk modeler and an Associate Member of the Chartered Institute for Securities & Investment (CISI), London. All posts reflect my personal opinions only and do not constitute, nor should they be interpreted as, financial advice or a recommendation to buy or sell any securities. 𝐑𝐢𝐬𝐤 𝐖𝐚𝐫𝐧𝐢𝐧𝐠𝐬: Copy Trading does not amount to investment advice | Your capital is at risk | Past performance is not indicative of future results.